Cliff Asness’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$709K Buy
+1,938
New +$663K ﹤0.01% 3261
2023
Q1
– Sell
-5,486
Closed -$1.21M – 2269
2022
Q4
$1.21M Sell
5,486
-72,021
-93% -$13.2M ﹤0.01% 1482
2022
Q3
$10.4M Sell
77,507
-104
-0.1% -$17.9K 0.03% 631
2022
Q2
$12.6M Sell
77,611
-341
-0.4% -$53.3K 0.03% 616
2022
Q1
$14.7M Sell
77,952
-729
-0.9% -$155K 0.03% 623
2021
Q4
$21.3M Sell
78,681
-2,235
-3% -$755K 0.04% 471
2021
Q3
$29.4M Sell
80,916
-513
-0.6% -$168K 0.05% 377
2021
Q2
$27.9M Buy
81,429
+22
+0% +$7.29K 0.05% 410
2021
Q1
$28.3M Buy
81,407
+18,914
+30% +$6.26M 0.05% 407
2020
Q4
$16.1M Buy
+62,493
New +$17.2M 0.03% 499

Other funds holding ONC

Cliff Asness's ONC Position: Q3 2026 in Review

Cliff Asness opened a new position in BeOne Medicines (ONC) in Q3 2026: 1,938 shares worth $709K. The stake represents ﹤0.01% of the portfolio and ranks #3261 among its holdings. This is a return to the name: Cliff Asness previously reported a position in ONC as recently as Q4 2022.

Cliff Asness first reported a position in ONC in Q4 2020 and has held it in 10 quarters since. The position peaked at $29.4M in Q3 2021. 325 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Cliff Asness held 1,938 shares of BeOne Medicines worth $709K as of Q3 2026.
  • BeOne Medicines was a new Cliff Asness position in Q3 2026.
  • BeOne Medicines made up ﹤0.01% of Cliff Asness's portfolio in Q3 2026, its #3261 holding.
  • Cliff Asness first reported a position in BeOne Medicines in Q4 2020 and has held it in 10 quarters since.
  • Cliff Asness's BeOne Medicines position peaked at $29.4M in Q3 2021.
  • 325 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.

Based on AQR Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.